BPC-157
Also: Body Protection Compound 157, Pentadecapeptide BPC 157, BPC 157, PL 14736
This profile summarizes research context only. It is not medical advice and does not describe how to use this compound in humans or animals — no dosing, administration, or protocols. Learn more
BPC-157 (Body Protection Compound 157) is a synthetic pentadecapeptide whose sequence corresponds to a fragment described in studies of a protein found in human gastric juice. It appears in the research literature mainly through preclinical (animal and in vitro) work exploring tissue-repair and cytoprotective pathways, while well-controlled human clinical data remain very limited. BPC-157 is not an approved drug and is treated here strictly as a research compound. Reported findings should be interpreted cautiously given the early stage and design limitations of the available studies.
Mechanism as described in the literature
In the research literature, BPC-157 is described as a relatively stable synthetic peptide derived from a partial sequence associated with a protein identified in gastric juice. Mechanistic discussion in preclinical and in vitro studies has centered on angiogenesis-related signaling (including pathways linked to vascular endothelial growth factor receptor activity and the nitric oxide system) and on reported interactions with growth-factor and cytoskeletal signaling observed in cell and animal models.
These mechanisms are best understood as hypotheses drawn largely from animal and cell-based experiments rather than established human pharmacology. Whether, and how, they translate to humans is uncertain and requires careful interpretation due to study-design and translation limitations.
Research areas
- Tissue-repair and cytoprotective pathways (preclinical)
- Angiogenesis-related signaling (in vitro / animal models)
- Gastrointestinal mucosal research (animal models)
- Connective-tissue and musculoskeletal models (preclinical)
- Nitric-oxide-system interactions described in vitro
Documentation notes
References
Frequently asked questions
What is BPC-157?+
BPC-157 is a synthetic pentadecapeptide (a 15-amino-acid sequence) studied primarily in preclinical animal and in vitro models. It is discussed in the research literature in the context of cytoprotective and tissue-repair pathways, but it is not an approved medicine and has no established human use.
Is there strong human evidence for BPC-157?+
No. The published evidence base is predominantly preclinical, and well-controlled human clinical data are very limited. Any statements about human relevance should be treated as preliminary and interpreted with caution because of study-design and translation limitations.
Is "BPC-157" a single, standardized compound?+
The name refers to a specific peptide sequence, but related designations (for example PL 14736) and differing preparations appear across sources. Because terminology and material quality vary, identity and documentation should be verified against primary literature and certificates of analysis rather than assumed.